EGFR and small cell lung carcinoma: However, shorter OS and PFS were observed in patients with TP53 mutations, while loss of function mutations in TP53 and RB1, occurring in nine percent of EGFR mutated cases, is associated with an increased risk of transformation into small cell lung cancer (SCLC).